Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial.

BACKGROUND Although osteoporosis is strongly associated with hip fractures, the initiation of osteoporosis treatment following hip fractures occurs at surprisingly low rates of between 5% and 30%. Currently, most patients receiving treatment have been referred back to their primary care physician for osteoporosis management. The purpose of this study was to compare the effect of osteoporosis management initiated by the orthopaedic team and osteoporosis management initiated by the primary care physician on the rates of treatment at six months. METHODS A prospective randomized trial was conducted to assess the difference in the rate of osteoporosis treatment when an in-house assessment of osteoporosis was initiated by the orthopaedic surgeon and follow-up was conducted in a specialized orthopaedic osteoporosis clinic compared with osteoporosis education and "usual" care. RESULTS Sixty-two patients were enrolled in the study. Thirty-one patients each were in the control and intervention groups. The percentage of patients who were on pharmacologic treatment for osteoporosis at six months after the fracture was significantly greater when the evaluation was initiated by the orthopaedic surgeon and was managed in a specialized orthopaedic osteoporosis clinic (58%) than when treatment was managed by a primary care physician (29%) (p = 0.04). CONCLUSIONS An active role by orthopaedic surgeons in the management of osteoporosis improves the rate of treatment at six months following a hip fracture.

[1]  S. Boonen,et al.  Zoledronic acid and clinical fractures and mortality after hip fracture. , 2007, The New England journal of medicine.

[2]  S. Cummings,et al.  Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. , 2007, The New England journal of medicine.

[3]  V. Pellegrini,et al.  The inpatient consultation approach to osteoporosis treatment in patients with a fracture. Is automatic consultation needed? , 2006, The Journal of bone and joint surgery. American volume.

[4]  D. Heinegård,et al.  Extracellular matrix in disc degeneration. , 2006, The Journal of bone and joint surgery. American volume.

[5]  B. Ettinger,et al.  Outcomes of a disease-management program for patients with recent osteoporotic fracture , 2006, Osteoporosis International.

[6]  E. Benjamin,et al.  Follow-up treatment for osteoporosis after fracture , 2005, Osteoporosis International.

[7]  D. Beaton,et al.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review , 2004, Osteoporosis International.

[8]  S. Boonen,et al.  Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis , 2004, Calcified Tissue International.

[9]  M. Aickin,et al.  Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. , 2003, The Journal of bone and joint surgery. American volume.

[10]  S. Gallacher,et al.  The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture , 2003, Osteoporosis International.

[11]  S. Greenspan,et al.  The management of osteoporosis following hip fracture: Have we improved our care? , 2003, Osteoporosis International.

[12]  J. Butler,et al.  Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. , 2003, Journal of the American College of Cardiology.

[13]  Richard Platt,et al.  Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. , 2003, Archives of internal medicine.

[14]  B. Edwards,et al.  Barriers and solutions to osteoporosis care in patients with a hip fracture. , 2003, The Journal of bone and joint surgery. American volume.

[15]  Dave Davis,et al.  Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process , 2003, Osteoporosis International.

[16]  G. Hawker,et al.  The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients , 2003, Osteoporosis International.

[17]  M. Mcdermott,et al.  Lack of Diagnosis and Treatment of Osteoporosis in Men and Women After Hip Fracture , 2003, Pharmacotherapy.

[18]  D. Shewmon,et al.  Hip fracture patients are not treated for osteoporosis: a call to action. , 2002, Arthritis and rheumatism.

[19]  L. Melton,et al.  Patient barriers to osteoporosis interventions after fracture. , 2002, Mayo Clinic proceedings.

[20]  M. Gardner,et al.  Improvement in the Undertreatment of Osteoporosis Following Hip Fracture , 2002, The Journal of bone and joint surgery. American volume.

[21]  C. Simonelli,et al.  Patient Barriers to Osteoporosis Interventions After Fracture–Reply–I , 2002 .

[22]  Susan Mehle,et al.  Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. , 2002, Mayo Clinic proceedings.

[23]  J. Meunier,et al.  Shear-induced first-order sponge-to-lamellar transition in a lyotropic surfactant system. , 2001, Physical review letters.

[24]  S. Cummings,et al.  Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  C. Pieper,et al.  The risk of subsequent fractures in community-dwelling men and male veterans with hip fracture. , 2000, The American journal of medicine.

[26]  H. Perry,et al.  Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. , 2000, The American journal of medicine.

[27]  W. Bilker,et al.  Treatment of Osteoporosis: Are Physicians Missing an Opportunity?*† , 2000, The Journal of bone and joint surgery. American volume.

[28]  David J Torgerson,et al.  Prescribing by general practitioners after an osteoporotic fracture , 1998, Annals of the rheumatic diseases.

[29]  T A Einhorn,et al.  Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[31]  M. Erlandsen,et al.  Occurrence and incidence of the second hip fracture. , 1993, Clinical orthopaedics and related research.

[32]  J. Wark,et al.  The prevention and treatment of osteoporosis. , 1993, The New England journal of medicine.

[33]  B. Riggs,et al.  Hip fracture recurrence. A population-based study. , 1982, Clinical orthopaedics and related research.

[34]  S. Berney,et al.  Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis , 2008 .

[35]  D. Beaton,et al.  Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. , 2006, The Journal of bone and joint surgery. American volume.

[36]  J. Skedros,et al.  Knowledge and opinions of orthopaedic surgeons concerning medical evaluation and treatment of patients with osteoporotic fracture. , 2006, The Journal of bone and joint surgery. American volume.

[37]  M. Gardner,et al.  Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. , 2005, The Journal of bone and joint surgery. American volume.

[38]  M. Utley,et al.  Opinions and Experiences in General Practice on Osteoporosis Prevention, Diagnosis and Management , 2001, Osteoporosis International.

[39]  D. Dirschl,et al.  Bone mineral density 6 years after a hip fracture: a prospective, longitudinal study. , 2000, Bone.

[40]  S. Zimmerman,et al.  Loss of Bone Density and Lean Body Mass after Hip Fracture , 2000, Osteoporosis International.